CoChat

Rho kinase inhibitors block activation of pancreatic stellate cells

Open access
Masamune, Atsushi, Kikuta, Kazuhiro, Satoh, Mashiro, Satoh, Kennichi, Shimosegawa, Tooru · 2003 · British Journal of Pharmacology
Cited by 92

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

In response to pancreatic injury and in cell culture, pancreatic stellate cells (PSCs) are transformed (‘activated’) into highly proliferative myofibroblast‐like cells, which express α‐smooth muscle actin (α‐SMA), and produce type I collagen and other extracellular matrix components. There is accumulating evidence that activated PSCs play important roles in pancreatic fibrosis and inflammation. The small GTP‐binding protein Rho has emerged as an important regulator of the actin cytoskeleton and cell morphology through the downstream effector Rho kinase (ROCK). But, the roles of Rho‐ROCK pathway in PSCs are unknown. Here, we examined the effects of (+)‐(R)‐trans‐4‐(1‐aminoethyl)‐N‐(4‐pyridyl) cyclohexanecarboxamide (Y‐27632) and HA‐1077 (fasudil), specific inhibitors of ROCK, on the activation of PSCs. PSCs were isolated from the pancreas of male Wistar rats after perfusion with collagenase P. The actin cytoskeleton was analyzed by phalloidin staining. Expression of RhoA and ROCK was examined by immunostaining and Western blotting. Effects of Y‐27632 and HA‐1077 on α‐SMA expression, platelet‐derived growth factor‐induced proliferation and chemotaxis, and collagen production were assessed. Culture‐activated PSCs developed a well‐spread cell shape, with extended stress fiber formation. PSCs expressed RhoA, ROCK‐1, and ROCK‐2. Y‐27632 caused disassembly of stress fibers. Y‐27632 and HA‐1077 inhibited α‐SMA expression, proliferation, chemotaxis, and type I collagen production in culture‐activated PSCs. In addition, Y‐27632 and HA‐1077 inhibited spontaneous activation of freshly isolated PSCs in culture on plastic. These findings suggest a role of Rho‐ROCK pathway in the activation process of PSCs by regulating the actin cytoskeleton, and a potential application of Rho‐ROCK pathway inhibitors for the treatment of pancreatic inflammation and fibrosis. British Journal of Pharmacology (2003) 140, 1292–1302. doi:10.1038/sj.bjp.0705551

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0705551

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 92

Metadata

Authors
Masamune, A., Kikuta, K., Satoh, M., Satoh, K., & Shimosegawa, T.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2003-12
Volume
140
Issue
7
Pages
1292-1302
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2055395938
Cited by
92
References
4
FWCI
7.21
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.